CEO SUMMARY: Evidence at the 2026 Executive War College suggests a coming push in clinical lab advocacy, focusing on the RESULTS Act to establish a permanent, database-driven reimbursement model. Simultaneously, federal regulators have floated the idea of heightened scrutiny of genetic test spending, signaling that while lab test reimbursement rates may stabilize, compliance oversight could […]
Expect RESULTS Act Vote by End of the Year
At the Executive War College, an insider panel provides updates on thorny legislative concerns
- By Scott Wallask
- > From the Volume XXXIII, No. 7 - May 26, 2026 Issue
- Tags: acla, American Clinical Laboratory Association, Anatomic pathology, Centers for Medicare and Medicaid Services, Clinical Laboratory Fee Schedule, CMS, compliance oversight, Comprehensive Regulations to Uncover Suspicious Healthcare rule, CRD Associates, CRUSH, DEX Diagnostic Exchange, durable medical equipment, Erin Morton, executive war college, FAIR Health database, Federal Register, genetic testing, HHS, jane pine wood, lab risk & compliance, Medicare Administrative Contractor, Medicare Advantage, Medicare claims, medicare fraud, Medicare Part B, MolDx, molecular diagnostic services, molecular testing, national independent laboratory association, New York State Clinica Laboratory Association, NILA, Office of Inspector General, OIG, Palmetto GBA, PAMA, Prior authorization, Protecting Access to Medicare Act, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act, Results Act, StopLabCuts.org, Susan Van Meter, US Department of Health and Human Services
